People / Staff

Angel Montero Carcaboso

Search publications

Publications

  • Monterrubio C, Paco-Mercader S, Vilà-Ubach M, Rodriguez E, Glisoni R, Lavarino C, Schaiquevich P, Sosnik A, Mora J and Carcaboso AM.

    Combined Microdialysis-Tumor Homogenate Method for the Study of the Steady State Compartmental Distribution of a Hydrophobic Anticancer Drug in Patient-Derived Xenografts

    PHARMACEUTICAL RESEARCH . 32(9): 2889-2900. Number of citations: 10

    [doi:10.1007/s11095-015-1671-9]

  • Ordóñez JL, Amaral AT, Carcaboso AM, Herrero-Martín D, Del Carmen García-Macías M, Sevillano V, Alonso D, Pascual-Pastó G, San-Segundo L, Vilà-Ubach M, Rodrigues T, Fraile S, Teodosio C, Mayo-Iscar A, Aracil M, Galmarini CM, Tirado OM, Mora J and de Álava E.

    The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin

    Oncotarget . 6(22): 18875-18890. Number of citations: 64

    [doi:10.18632/oncotarget.4303]

  • Cockle JV, Picton S, Levesley J, Ilett E, Carcaboso AM, Short S, Steel LP, Melcher A, Lawler SE and Brüning-Richardson A.

    Cell migration in paediatric glioma; characterisation and potential therapeutic targeting

    BRITISH JOURNAL OF CANCER . 112(4): 693-703. Number of citations: 25

    [doi:10.1038/bjc.2015.16]

  • Schaiquevich P, Carcaboso AM, Buitrago E, Taich P, Opezzo J, Bramuglia G and Chantada GL.

    OCULAR PHARMACOLOGY OF TOPOTECAN AND ITS ACTIVITY IN RETINOBLASTOMA

    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES . 34(9): 1719-1727. Number of citations: 31

    [doi:10.1097/IAE.0000000000000253]

  • Sosnik A and Carcaboso AM.

    Nanomedicines in the future of pediatric therapy

    ADVANCED DRUG DELIVERY REVIEWS . 73: 140-161. Number of citations: 47

    [doi:10.1016/j.addr.2014.05.004]

  • Parareda A, Català-Mora J, Carcaboso AM, Sola T, Cruz-Martínez O, Díaz J, Salvador-Hernandez H, de Torres C, Álvarez-Sampons A, Suñol M, Vinent J, Guimaraens L, Prat-Bartomeu J and Mora J.

    Intra-arterial chemotherapy for retinoblastoma. Challenges of a prospective study

    ACTA OPHTHALMOLOGICA . 92(3): 209-215. Number of citations: 27

    [doi:10.1111/aos.12295]

  • Taylor KR, Mackay A, Truffaux N, Butterfield YS, Morozova O, Philippe C, Castel D, Grasso CS, Vinci M, Carvalho D, Carcaboso AM, de Torres C, Cruz-Martínez O, Mora J, Entz-Werle N, Ingram WJ, Monje M, Hargrave D, Bullock AN, Puget S, Yip S, Jones C and Grill J.

    Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma

    NATURE GENETICS . 46(5): 457-461. Number of citations: 412

    [doi:10.1038/ng.2925]

  • Elmeliegy MA, Carcaboso AM, L Chow LM, Zhang ZM, Calabrese C, Throm SL, Wang F, Baker SJ and Stewart CF.

    Magnetic Resonance Imaging-Guided Microdialysis Cannula Implantation in a Spontaneous High-Grade Glioma Murine Model

    JOURNAL OF PHARMACEUTICAL SCIENCES . 100(10): 4210-4214. Number of citations: 9

    [doi:10.1002/jps.22723]

  • Atkinson JM, Shelat AA, Carcaboso AM, Kranenburg TA, Arnold LA, Boulos N, Wright K, Johnson RA, Poppleton H, Mohankumar KM, Féau C, Phoenix T, Gibson P, Zhu L, Tong Y, Eden C, Ellison DW, Priebe W, Koul D, Yung WK, Gajjar A, Stewart CF, Guy RK and Gilbertson RJ.

    An Integrated In Vitro and In Vivo High-Throughput Screen Identifies Treatment Leads for Ependymoma

    Cancer Cell . 20(3): 384-399. Number of citations: 94

    [doi:10.1016/j.ccr.2011.08.013]

  • Nemeth KM, Federico S, Carcaboso AM, Shen Y, Schaiquevich P, Zhang J, Egorin M, Stewart C and Dyer MA.

    Subconjunctival Carboplatin and Systemic Topotecan Treatment in Preclinical Models of Retinoblastoma

    CANCER . 117(2): 421-434. Number of citations: 44

    [doi:10.1002/cncr.25574]